Evidence map›Paper›PMID 26230094›Full record

ArticlePloS one2015

A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.

Xianqiong Gong, Jiaen Yang, Jinmo Tang, Chong Gu, Lijian Huang, Ying Zheng, Huiqing Liang, Min Wang, Chuncheng Wu, Yue Chen and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. [Expert opinion on expanding anti-HBV treatment for chronic hepatitis B].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Association between Serum Liver Enzymes and Metabolic Syndrome in Korean Adults.International journal of environmental research and public health · 2018
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Xianqiong GongHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Jiaen YangHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Jinmo TangHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Chong GuHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Lijian HuangHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Ying ZhengHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Huiqing LiangHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Min WangHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Chuncheng WuHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Yue ChenHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Manying ZhangHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Zhijian YuShenzhen Key Lab for Endogenous Infection, Shenzhen Nanshan Hospital, Shenzhen, Guangdong, China.
Qianguo MaoHepatology Unit, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Union Hospital · CNAnshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To understand the mechanisms underlying the discordance between normal serum alanine aminotransferase (ALT) levels and significant alterations in liver histology of chronic hepatitis B virus (HBV) infection with persistent normal ALT (PNALT) or minimally elevated ALT. A total of 300 treatment-naive chronic HBV-infected patients with PNALT (ALT ≤ upper limit of normal [ULN, 40 U/ml]) or minimally elevated ALT (1-2×ULN) were retrospectively enrolled. All patients underwent liver biopsy and histological changes were analyzed along with biochemical and HBV markers. Among 300 participants, 177 were HBeAg-positive and 123 HBeAg-negative. Significant histologic abnormalities were found in 42.9% (76/177) and 52.8% (65/123) of HBeAg-positive and HBeAg-negative patients, respectively. Significant fibrosis, which is a marker of prior injury, was more frequently detected than significant necroinflammation (suggesting active liver injury) in both HBeAg-positive and -negative groups, suggesting that liver injury occurred intermittently in our cohort. No significant differences were noticed in the percentage of patients with severe fibrosis between HBeAg-positive and negative phases or between ages 30 and 40 and over 40, suggesting that the fibrosis was possibly carried over from an early phase. Finally, lowering ALT ULN (30 U/L for men, 19 U/L for women) alone was not adequate to increase the sensitivity of ALT detection of liver injury. However, the study was limited to a small sample size of 13 HBeAg-positive patients with ALT in the revised normal range. We detected significant liver pathology in almost 50% of chronic HBV infected patients with PNALT (ALT ≤ 40 U/ml) or minimally elevated ALT. We postulated that small-scale intermittent liver injury was possibly responsible for the discordance between normal serum ALT and significant liver changes in our cohort.

Indexed as

AdultAlanine TransaminaseFemaleHepatitis B, ChronicHumansLiverMaleAlanine Transaminase

Identifiers

PMID26230094
PMCPMC4521718
OpenAlexW2198040437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.